OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crossed Pathways for Radiation-Induced and Immunotherapy-Related Lung Injury
Zengfu Zhang, Jialin Zhou, Vivek Verma, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59

Showing 26-50 of 59 citing articles:

Pioneering Immunotherapy Agents and Their Synergy with Radiotherapy
Xiaofeng Zhang, Li Zheng, Lei‐Ming Cao, et al.
(2025), pp. 191-231
Closed Access

A Systematic Review of Pneumonitis Following Treatment with Immune Checkpoint Inhibitors and Radiotherapy
Melina Yerolatsite, Nanteznta Torounidou, Anna-Lea Amylidi, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 946-946
Open Access

Development and validation of a CT-based radiomics machine learning model for differentiating immune-related interstitial pneumonia
Tingyue Luo, Jingze Guo, Junjie Xi, et al.
International Immunopharmacology (2025) Vol. 156, pp. 114681-114681
Open Access

Enhancing outcomes in metastatic renal cell carcinoma: Integrating precision radiotherapy with targeted therapy and anti-PD-1 immunotherapy
Mingwei Ma, Kaiwei Yang, Xianshu Gao, et al.
Urologic Oncology Seminars and Original Investigations (2025)
Open Access

Validated machine learning tools to distinguish immune checkpoint inhibitor, radiotherapy, COVID-19 and other infective pneumonitis
Sumeet Hindocha, Benjamin Hunter, Kristofer Linton‐Reid, et al.
Radiotherapy and Oncology (2024) Vol. 195, pp. 110266-110266
Open Access | Times Cited: 3

Regenerating murine CD8+ lung tissue resident memory T cells after targeted radiation exposure
Mariah Hassert, Lecia L. Pewe, Rui He, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 3
Open Access | Times Cited: 3

Glycyrrhizin Protects Submandibular Gland Against Radiation Damage by Enhancing Antioxidant Defense and Preserving Mitochondrial Homeostasis
Xin-Ru Zhou, Xin-Yue Wang, Yue-Mei Sun, et al.
Antioxidants and Redox Signaling (2023) Vol. 41, Iss. 10-12, pp. 723-743
Closed Access | Times Cited: 7

Cancer treatments as paradoxical catalysts of tumor awakening in the lung
Émmanuelle Nicolas, Beata Kośmider, Edna Cukierman, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 4, pp. 1165-1183
Open Access | Times Cited: 2

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
Anqi Zhang, Fuyuan Yang, Lei Gao, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 2469-2483
Open Access | Times Cited: 11

Spectrum of Imaging Patterns of Lung Cancer following Radiation Therapy
Taylor A. Strange, Lauren T. Erasmus, Jitesh Ahuja, et al.
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3283-3283
Open Access | Times Cited: 6

Bibliometric analysis of global research trends on pyroptosis in lung disease
Wei Mo, Quanfu Li, Huanping Zhou, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9

Mesenchymal Stem Cells in Radiation-Induced Pulmonary Fibrosis: Future Prospects
Yusha Chen, Xuefeng Liu, Zhaohui Tong
Cells (2022) Vol. 12, Iss. 1, pp. 6-6
Open Access | Times Cited: 9

IDO1 Activity Predicts Lung Toxicity in Patients with Unresectable Stage III NSCLC and Chemoradiotherapy
Linfang Wu, Yibo Gao, Daquan Wang, et al.
Journal of Oncology (2023) Vol. 2023, pp. 1-8
Open Access | Times Cited: 5

Influence of the irradiated pulmonary microenvironment on macrophage and T cell dynamics
Angela M. Groves, Ravi Misra, Gérémy Clair, et al.
Radiotherapy and Oncology (2023) Vol. 183, pp. 109543-109543
Open Access | Times Cited: 5

Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance
Juan Wang, Jingxin Zhang, Weitao Wen, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 7, pp. 166789-166789
Open Access | Times Cited: 5

Pyroptosis in glioma: Current management and future application
Zeshang Guo, Zhenjin Su, Ying Wei, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 152-168
Closed Access | Times Cited: 5

TNKS1BP1 mediates AECII senescence and radiation induced lung injury through suppressing EEF2 degradation
Jiaojiao Zhu, Xingkun Ao, Yuhao Liu, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy
Xueying Wang, Haoyu Zhang, XinZhang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Clinical, dosimetric and radiomics features predictive of lung toxicity after (chemo)radiotherapy
Cécile Evin, Léo Razakamanantsoa, François Gardavaud, et al.
Clinical Lung Cancer (2024)
Closed Access | Times Cited: 1

ALDH2 attenuates radiation-induced lung injury by inhibiting ROS and epithelial-mesenchymal transition mediated by the TGF-β1/Smad pathway
E. Li, Jianliang Huang, Jingyi Huang, et al.
Pulmonary Pharmacology & Therapeutics (2024) Vol. 87, pp. 102334-102334
Open Access | Times Cited: 1

Pyroptosis: A promising target for lung cancer therapy
Wensheng Zhou, Lishu Zhao, Hao Wang, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 94-101
Open Access | Times Cited: 3

Scroll to top